SIRT5 Contributes to Colorectal Cancer Growth by Regulating T Cell Activity

Ke Wang1, Zuojian Hu2, Cuiping Zhang1,3

  • 1Institutes of Biomedical Sciences & Minhang Hospital, Shanghai Medical College, Fudan University, Shanghai 200032, China.

Insights

Mice lacking SIRT5 resist colorectal cancer development by enhancing T cell responses and increasing anti-tumor immunity. This study reveals SIRT5

Area of Science:

  • Immunology
  • Oncology
  • Biochemistry

Background:

  • Sirtuin 5 (SIRT5) is recognized for its role in metabolic regulation.
  • The specific function of SIRT5 in tumorigenesis, particularly its influence on the tumor microenvironment, remains largely uncharacterized.

Purpose of the Study:

  • To investigate the role of SIRT5 in colitis-associated colorectal tumorigenesis.
  • To elucidate the mechanisms by which SIRT5 affects the tumor microenvironment and immune cell function.

Main Methods:

  • Utilized knockout mouse models (Sirt5-/-) subjected to AOM/DSS induction for colitis-associated colorectal cancer.
  • Performed proteomic and network analyses to identify molecular pathways affected by SIRT5.
  • Assessed T cell activation, differentiation of CD4+ regulatory T (Treg) cells, and T helper 1 (Th1) cells.

Main Results:

  • Sirt5 knockout mice exhibited resistance to AOM/DSS-induced colorectal tumorigenesis.
  • Elevated levels of interferon-gamma (IFN-γ) were observed in the tumor microenvironment of Sirt5 knockout mice.
  • SIRT5 deficiency led to enhanced T cell activation and altered differentiation of Treg and Th1 cells, impacting the balance of immune cells.

Conclusions:

  • SIRT5 plays a critical role in regulating T cell activation and differentiation.
  • The balance between immunosuppressive Treg cells and inflammatory Th1 cells, influenced by SIRT5, is crucial in colon cancer development.
  • SIRT5 emerges as a key regulator in colorectal tumorigenesis through its modulation of the tumor immune microenvironment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.7K
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.0K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K